Nav: Home

Immune compound blocks virus' ability to hijack antibodies

December 12, 2007

St. Louis, Dec. 11, 2007 -- Researchers at Washington University School of Medicine in St. Louis have shown that a controversial phenomenon known as antibody-dependent enhancement (ADE) of infection is suppressed by C1q, a blood-borne immune system compound.

The link may give researchers the lead they need to begin untangling a snarl of evidence from decades of puzzling epidemiological and laboratory-based studies of ADE. Better understanding of ADE will help public health experts and clinicians working to control some viral disease outbreaks and aid efforts to design safe and effective vaccines.

ADE reverses the conventional picture of immune resistance to disease, which says victory over an invader leaves the body better prepared to fight the invader if it returns. In the 1960s, though, epidemiological studies of dengue fever virus infections showed that patients who had beaten the virus once could be more vulnerable to it when they became infected again with a related but not identical strain.

Scientists theorized that the vulnerable patients didn't have adequate antibodies to eradicate the dengue virus when it returned, and that as a result the virus was somehow taking advantage of the antibodies and using them to accelerate infection. The theory was based on evidence from experiments in cell cultures, where adding virus to blood serum with low levels of antibodies led to higher viral replication levels. However, when researchers tried to simulate the phenomenon in animal models, they could not.

"In theory, this should be a very easy model to make," says senior author Michael Diamond, M.D., Ph.D., associate professor of molecular microbiology, of pathology and immunology and of medicine. "Part of the problem has been a lack of good animal models of dengue infection, but cell culture studies have suggested ADE also may play a role in other types of viral infection. And yet we still have had only three partially successful animal models of ADE, and that had some people suggesting that maybe ADE only happens in cell cultures, not in whole organisms."

One major problem, Diamond and his colleagues report this week in Cell Host & Microbe, was that cell culture experiments had unknowingly used blood sera where a key immune compound, C1q, had broken down or was at inadequate concentrations.

"We started by noting that the epidemiological data on ADE suggest it happens only very rarely," Diamond explains. "That made us wonder: why is it so rare if you can make it happen in a lab dish so easily? Is something important missing in the cell culture experiments that can suppress ADE?"

Researchers began their search for a potential missing suppressor in the complement system, a family of immune compounds that normally circulate in the bloodstream. When the immune system detects an invader, it can activate these compounds, transforming them into inhibitors against the invader. But unless blood sera are carefully procured, processed and stored, complement proteins break down very easily.

Exposure to heat, for example, breaks down complement. So researchers conducted an ADE test, but instead of using stored blood sera, they took fresh sera from mice and applied it to dengue virus and therapeutic antibodies for dengue. Fresh, unheated sera blocked ADE; heated sera, which lacks complement, did not.

Scientists next tested sera from several different lines of mice, each genetically engineered to be missing one component of complement. Only sera from mice missing C1q led to ADE in cell cultures. When they added purified C1q to virus and antibodies, it blocked ADE.

Although they have now firmly linked C1q to ADE suppression, the researchers found evidence in follow-up experiments that other immune factors also affect the chances that ADE will occur. An initial attempt by Diamond's lab to simulate ADE in a mouse model of West Nile virus infection, for example, had limited success. But he and his colleagues are hopeful that C1q is the lead they need to begin assembling a complete picture of what happens in ADE and to potentially one day open the door to the development of therapeutic or preventive treatments.


Washington University School of Medicine

Related Antibodies Articles:

Researchers discover first human antibodies that work against all ebolaviruses
After analyzing the blood of a survivor of the 2013-16 Ebola outbreak, a team of scientists from academia, industry and the government has discovered the first natural human antibodies that can neutralize and protect animals against all three major disease-causing ebolaviruses.
New method enables creation of better therapeutic antibodies
Researchers from the University of Maryland and Rockefeller University have refined a method to modify an antibody's sugar group structure, which plays a large role in determining an antibody's ability to activate the immune response.
Antibodies as 'messengers' in the nervous system
Antibodies are able to activate human nerve cells within milliseconds and hence modify their function -- that is the surprising conclusion of a study carried out at Human Biology at the Technical University of Munich (TUM).
Turning therapeutic antibodies inside-out to fight cancer
Researchers at the University of California, Riverside have camels and llamas to thank for their development of a new cancer treatment that is highly selective in blocking the action of faulty matrix metalloproteinases (MMPs).
Zika antibodies from infected patient thwart infection in mice
Researchers have identified neutralizing antibodies against Zika virus from an infected patient that fully protected mice from infection, adding to the current arsenal of antibodies in development for much needed antiviral therapies and vaccines.

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...